FDA Approves FILKRI Filgrastim Biosimilar
Accord BioPharma, the United States specialty division of Intas Pharmaceuticals Ltd., announced that the US Food and Drug Administration has approved FILKRI filgrastim laha, a biosimilar referencing NEUPOGEN filgrastim....